Using COTS at the LHC: building on space experience

por Kinnison, J D, Roth, D R
Publicado 1999

Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program

por Yapa, S Wickramaratne Senarath, Roth, D, Gordon, D, Struemper, H
Publicado 2016

Long-Term Training-Induced Gains of an Auditory Skill in School-Age Children As Compared With Adults

por Zaltz, Y., Ari-Even Roth, D., Karni, A., Kishon-Rabin, L.
Publicado 2018

Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab

por Roth, D A, Thompson, A, Tang, Y, Hammer, A E, Molta, C T, Gordon, D
Publicado 2015

Impact of concomitant medication use on belimumab efficacy and safety in patients with systemic lupus erythematosus

por Schwarting, A, Dooley, M A, Roth, D A, Edwards, L, Thompson, A, Wilson, B
Publicado 2016

A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus

por Chatham, W, Chadha, A, Fettiplace, J, Kleoudis, C, Bass, D, Roth, D, Gordon, D
Publicado 2017

Increase in electron scattering length in PEDOT:PSS by a triflic acid post-processing

por Farka, Dominik, Coskun, H., Bauer, P., Roth, D., Bruckner, B., Klapetek, Petr, Sariciftci, N. Serdar, Stadler, P.
Publicado 2017

Project HELP: a study protocol to pilot test a shared decision-making tool about treatment options for patients with hepatitis C and chronic kidney disease

por Politi, M. C., George, N., Li, T., Korenblat, K. M., Fowler, K. J., Ho, C., Liapakis, A., Roth, D., Yee, J.
Publicado 2018

Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care

por Bruce, I N, Urowitz, M, van Vollenhoven, R, Aranow, C, Fettiplace, J, Oldham, M, Wilson, B, Molta, C, Roth, D, Gordon, D
Publicado 2016

A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus

por Doria, A, Bass, D, Schwarting, A, Hammer, A, Gordon, D, Scheinberg, M, Fox, N L, Groark, J, Stohl, W, Kleoudis, C, Roth, D
Publicado 2018

Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus

por Doria, A., Stohl, W., Schwarting, A., Okada, M., Scheinberg, M., van Vollenhoven, R., Hammer, A. E., Groark, J., Bass, D., Fox, N. L., Roth, D., Gordon, D.
Publicado 2018

Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma

por Karremann, M, Rausche, U, Roth, D, Kühn, A, Pietsch, T, Gielen, G H, Warmuth-Metz, M, Kortmann, R-D, Straeter, R, Gnekow, A, Wolff, J E A, Kramm, C M
Publicado 2013

Whole genome sequencing for improved understanding of Mycobacterium tuberculosis transmission in a remote circumpolar region

por Guthrie, J. L., Strudwick, L., Roberts, B., Allen, M., McFadzen, J., Roth, D., Jorgensen, D., Rodrigues, M., Tang, P., Hanley, B., Johnston, J., Cook, V. J., Gardy, J. L.
Publicado 2019

Comparison of routine field epidemiology and whole genome sequencing to identify tuberculosis transmission in a remote setting

por Guthrie, J. L., Strudwick, L., Roberts, B., Allen, M., McFadzen, J., Roth, D., Jorgensen, D., Rodrigues, M., Tang, P., Hanley, B., Johnston, J., Cook, V. J., Gardy, J.L.
Publicado 2020

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT...

por DeZern, A., Marconi, G., Deeren, D., Diez Campelo, M., Lübbert, M., Krishnamurthy, P., Nagy, Z., Basak, G., Jonášová, A., Morozova, E., Geissler, K., Ofran, Y., Kelley, H., Volkert, A., Baker, K., Kang-Fortner, Q., Hodgson, G., Madigan, C., Roth, D. A., Kelly, M., Fenaux, P.
Publicado 2022